tradmap

APVO Earnings Aptevo Therapeutics Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$31460 -$15729 $2 $0 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $16M $32M 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$112M -$52M $8M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$4459 -$2221 $17 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Net income (quarterly)
-$8M -$4M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income
Return on equity (quarterly)
-133% 151% 435% 0% Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
ROE

Reported EPS history

1–24 of 24
Q2 20262026-06-30-11.192026-08-1410-Q
Q1 20262026-03-31-6.412026-05-1310-Q
FY 20252025-12-31-87.272026-03-2610-K
Q3 20252025-09-30-11.422025-11-0610-Q
Q2 20262025-06-30-555.082026-08-1410-Q
Q1 20262025-03-31-1581.812026-05-1310-Q
FY 20252024-12-31-31460.232026-03-2610-K
Q3 20252024-09-30-3709.762025-11-0610-Q
Q2 20252024-06-30-4458.982025-08-1110-Q
Q1 20252024-03-31-368.212025-05-1510-Q
FY 20242023-12-31-2316.832025-02-1410-K
Q3 20242023-09-30-56.222024-11-0710-Q
Q2 20242023-06-30-31.672024-08-0810-Q
Q1 20242023-03-3117.382024-05-0810-Q
FY 20232022-12-311.572024-03-0510-K
Q3 20232022-09-302.522023-11-1410-Q
Q2 20232022-06-304.082023-08-1010-Q
Q1 20232022-03-31-1.552023-05-1110-Q
FY 20222021-12-31-6.072023-03-3010-K
Q3 20222021-09-30-4.802022-11-1010-Q
Q2 20222021-06-30-3.392022-08-1110-Q
Q3 20182018-09-30-1.772018-11-1410-Q
Q3 20182017-09-300.792018-11-1410-Q
Q3 20172016-09-30-4.822017-11-1310-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.